BCAXBicara Therapeutics Inc.
- Market cap
- $1.13B
- as of 2026-10-23
- Latest close
- $17.07
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-09-16
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Cohlhepp RyanPresident, COO & Interim CEO | Sep 8 | Sep 10 | M | 17,500 | $3.79 | $66,325 | 199,141 | Yes | Form 4 |
| Cohlhepp RyanPresident, COO & Interim CEO | Sep 8 | Sep 10 | S | 14,058 | $22.77 | Sale −$320,101 | 185,083 | Yes | Form 4 |
| Cohlhepp RyanPresident, COO & Interim CEO | Sep 8 | Sep 10 | S | 3,442 | $23.43 | Sale −$80,646 | 181,641 | Yes | Form 4 |
| Cohlhepp RyanPresident, COO & Interim CEO | Sep 8 | Sep 10 | M · derivative | 17,500 | $3.79 | $66,325 | 34,252 | Yes | Form 4 |
| Larson JenniferChief Financial Officer | Aug 12 | Aug 14 | A · derivative | 285,000 | $24.63 | $7,019,550 | 285,000 | No | Form 4 |
| Cohlhepp RyanPresident and COO | Aug 10 | Aug 12 | M | 18,750 | $3.79 | $71,063 | 200,391 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Aug 10 | Aug 12 | S | 18,750 | $27.98 | Sale −$524,625 | 181,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Aug 10 | Aug 12 | M · derivative | 18,750 | $3.79 | $71,063 | 51,752 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Aug 10 | Aug 12 | M | 10,000 | $3.79 | $37,900 | 372,152 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Aug 10 | Aug 12 | S | 10,000 | $27.98 | Sale −$279,800 | 362,152 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Aug 10 | Aug 12 | M · derivative | 10,000 | $3.79 | $37,900 | 110,546 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Aug 10 | Aug 12 | M | 12,500 | $3.79 | $47,375 | 142,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Aug 10 | Aug 12 | S | 12,500 | $27.97 | Sale −$349,625 | 129,855 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Aug 10 | Aug 12 | M · derivative | 12,500 | $3.79 | $47,375 | 26,336 | Yes | Form 4 |
| Oliger Christy J. | Jul 28 | Jul 29 | A · derivative | 38,950 | $26.88 | $1,046,976 | 38,950 | No | Form 4 |
| Bender Jeremy | Jul 28 | Jul 29 | A · derivative | 38,950 | $26.88 | $1,046,976 | 38,950 | No | Form 4 |
| Mazumdar ClaireChief Executive Officer | Jul 10 | Jul 14 | M | 10,000 | $3.79 | $37,900 | 372,152 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Jul 10 | Jul 14 | S | 9,972 | $28.42 | Sale −$283,404 | 362,180 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Jul 10 | Jul 14 | S | 28 | $29.68 | Sale −$831 | 362,152 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Jul 10 | Jul 14 | M · derivative | 10,000 | $3.79 | $37,900 | 120,546 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Jul 9 | Jul 10 | S | 536 | $29.00 | Sale −$15,544 | 181,641 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Jul 8 | Jul 10 | M | 12,500 | $3.79 | $47,375 | 157,855 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Jul 8 | Jul 10 | S | 22,757 | $28.60 | Sale −$650,850 | 135,098 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Jul 8 | Jul 10 | S | 4,413 | $29.82 | Sale −$131,596 | 130,685 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Jul 8 | Jul 10 | S | 830 | $30.31 | Sale −$25,157 | 129,855 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Jul 8 | Jul 10 | M · derivative | 11,592 | $3.79 | $43,934 | 58,992 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Jul 8 | Jul 10 | M · derivative | 908 | $3.79 | $3,441 | 38,836 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Jul 8 | Jul 10 | M | 18,750 | $3.79 | $71,063 | 210,391 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Jul 8 | Jul 10 | S | 22,833 | $28.76 | Sale −$656,677 | 187,558 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Jul 8 | Jul 10 | S | 4,306 | $29.80 | Sale −$128,319 | 183,252 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Jul 8 | Jul 10 | S | 1,075 | $30.35 | Sale −$32,626 | 182,177 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Jul 8 | Jul 10 | M · derivative | 18,750 | $3.79 | $71,063 | 70,502 | Yes | Form 4 |
| Shah Rajeev M. | Jun 9 | Jun 10 | A · derivative | 19,475 | $20.56 | $400,406 | 19,475 | No | Form 4 |
| Simson Jake | Jun 9 | Jun 10 | A · derivative | 19,475 | $20.56 | $400,406 | 19,475 | No | Form 4 |
| Powell Michael | Jun 9 | Jun 10 | A · derivative | 19,475 | $20.56 | $400,406 | 19,475 | No | Form 4 |
| Robertson Scott M. | Jun 9 | Jun 10 | A · derivative | 19,475 | $20.56 | $400,406 | 19,475 | No | Form 4 |
| Mazumdar-Shaw Kiran | Jun 9 | Jun 10 | A · derivative | 19,475 | $20.56 | $400,406 | 19,475 | No | Form 4 |
| Haviland Kate | Jun 9 | Jun 10 | A · derivative | 19,475 | $20.56 | $400,406 | 19,475 | No | Form 4 |
| Bowden Christopher | Jun 9 | Jun 10 | A · derivative | 19,475 | $20.56 | $400,406 | 19,475 | No | Form 4 |
| Hyep IvanChief Financial Officer | May 21 | May 26 | M | 9,200 | $3.79 | $34,868 | 154,555 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | May 21 | May 26 | S | 9,200 | $20.42 | Sale −$187,864 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | May 21 | May 26 | M · derivative | 9,200 | $3.79 | $34,868 | 70,584 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | May 18 | May 20 | M | 15,000 | $3.79 | $56,850 | 377,152 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | May 18 | May 20 | S | 12,022 | $19.96 | Sale −$239,959 | 365,130 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | May 18 | May 20 | S | 2,978 | $20.35 | Sale −$60,602 | 362,152 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | May 18 | May 20 | M · derivative | 15,000 | $3.79 | $56,850 | 146,107 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | May 15 | May 18 | M | 8,000 | $3.79 | $30,320 | 204,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | May 15 | May 18 | S | 8,000 | $20.29 | Sale −$162,320 | 196,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | May 15 | May 18 | S | 4,500 | $20.29 | Sale −$91,305 | 191,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | May 15 | May 18 | M · derivative | 8,000 | $3.79 | $30,320 | 101,334 | Yes | Form 4 |
| Schelman WilliamChief Medical Officer | May 8 | May 12 | A · derivative | 85,000 | $22.58 | $1,919,300 | 85,000 | No | Form 4 |
| Raben DavidChief Medical Officer | Apr 27 | Apr 28 | M | 5,500 | $3.79 | $20,845 | 60,786 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Apr 27 | Apr 28 | S | 5,500 | $22.88 | Sale −$125,840 | 55,286 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Apr 27 | Apr 28 | M · derivative | 5,500 | $3.79 | $20,845 | 41,913 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Apr 21 | Apr 22 | M | 9,200 | $3.79 | $34,868 | 154,555 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Apr 21 | Apr 22 | S | 9,200 | $23.00 | Sale −$211,600 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Apr 21 | Apr 22 | M · derivative | 9,200 | $3.79 | $34,868 | 39,744 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Apr 20 | Apr 20 | M | 15,000 | $3.79 | $56,850 | 377,152 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Apr 20 | Apr 20 | S | 15,000 | $23.61 | Sale −$354,150 | 362,152 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Apr 20 | Apr 20 | M · derivative | 15,000 | $3.79 | $56,850 | 161,107 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Apr 16 | Apr 20 | M | 8,226 | $4.44 | $36,523 | 347,618 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Apr 16 | Apr 20 | M | 7,454 | $3.79 | $28,251 | 355,072 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Apr 16 | Apr 20 | M | 7,080 | $5.45 | $38,586 | 362,152 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Apr 16 | Apr 20 | M · derivative | 8,226 | $4.44 | $36,523 | 56,684 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Apr 16 | Apr 20 | M · derivative | 7,454 | $3.79 | $28,251 | 130,546 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Apr 16 | Apr 20 | M · derivative | 7,080 | $5.45 | $38,586 | 558,432 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Apr 15 | Apr 17 | M | 8,000 | $3.79 | $30,320 | 208,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Apr 15 | Apr 17 | S | 8,000 | $23.01 | Sale −$184,080 | 200,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Apr 15 | Apr 17 | S | 4,500 | $23.01 | Sale −$103,545 | 196,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Apr 15 | Apr 17 | M · derivative | 8,000 | $3.79 | $30,320 | 109,334 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Mar 25 | Mar 26 | M | 5,500 | $3.79 | $20,845 | 60,786 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Mar 25 | Mar 26 | S | 5,500 | $18.95 | Sale −$104,225 | 55,286 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Mar 25 | Mar 26 | M · derivative | 5,500 | $3.79 | $20,845 | 47,413 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 23 | Mar 24 | M | 9,200 | $3.79 | $34,868 | 154,555 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 23 | Mar 24 | S | 9,200 | $18.52 | Sale −$170,384 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 23 | Mar 24 | M · derivative | 9,200 | $3.79 | $34,868 | 48,944 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 20 | Mar 20 | M | 1,596 | $3.79 | $6,049 | 340,988 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 20 | Mar 20 | S | 1,596 | $18.95 | Sale −$30,244 | 339,392 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 20 | Mar 20 | M · derivative | 1,596 | $3.79 | $6,049 | 176,107 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 19 | Mar 20 | M | 6,905 | $3.79 | $26,170 | 346,297 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 19 | Mar 20 | S | 6,905 | $18.78 | Sale −$129,676 | 339,392 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 19 | Mar 20 | M · derivative | 6,905 | $3.79 | $26,170 | 177,703 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 18 | Mar 20 | M | 6,499 | $3.79 | $24,631 | 345,891 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 18 | Mar 20 | S | 6,499 | $18.84 | Sale −$122,441 | 339,392 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 18 | Mar 20 | M · derivative | 6,499 | $3.79 | $24,631 | 184,608 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Mar 16 | Mar 17 | M | 8,000 | $3.79 | $30,320 | 213,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Mar 16 | Mar 17 | S | 8,000 | $19.66 | Sale −$157,280 | 205,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Mar 16 | Mar 17 | S | 4,500 | $19.66 | Sale −$88,470 | 200,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Mar 16 | Mar 17 | M · derivative | 8,000 | $3.79 | $30,320 | 117,334 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 9 | Mar 11 | M | 36,766 | $3.79 | $139,343 | 376,158 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 9 | Mar 11 | S | 36,766 | $19.17 | Sale −$704,804 | 339,392 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 9 | Mar 11 | M · derivative | 36,766 | $3.79 | $139,343 | 191,107 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 6 | Mar 6 | M | 3,817 | $3.79 | $14,466 | 343,209 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 6 | Mar 6 | S | 3,817 | $18.75 | Sale −$71,569 | 339,392 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 6 | Mar 6 | M · derivative | 3,817 | $3.79 | $14,466 | 227,873 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 5 | Mar 6 | M | 1,786 | $3.79 | $6,769 | 341,178 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 5 | Mar 6 | S | 1,786 | $18.74 | Sale −$33,470 | 339,392 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 5 | Mar 6 | M · derivative | 1,786 | $3.79 | $6,769 | 231,690 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 4 | Mar 6 | M | 2,631 | $3.79 | $9,971 | 342,023 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 4 | Mar 6 | S | 2,631 | $18.73 | Sale −$49,279 | 339,392 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Mar 4 | Mar 6 | M · derivative | 2,631 | $3.79 | $9,971 | 233,476 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Mar 4 | Mar 5 | M | 16,300 | $3.79 | $61,777 | 71,586 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Mar 4 | Mar 5 | S | 16,300 | $18.52 | Sale −$301,876 | 55,286 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Mar 4 | Mar 5 | M · derivative | 16,300 | $3.79 | $61,777 | 52,913 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 4 | Mar 5 | M | 2,963 | $3.79 | $11,230 | 148,318 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 4 | Mar 5 | S | 2,963 | $18.25 | Sale −$54,075 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 4 | Mar 5 | M · derivative | 2,963 | $3.79 | $11,230 | 79,784 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Mar 3 | Mar 5 | M | 200 | $3.79 | $758 | 55,486 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Mar 3 | Mar 5 | S | 200 | $18.45 | Sale −$3,690 | 55,286 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Mar 3 | Mar 5 | M · derivative | 200 | $3.79 | $758 | 69,213 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 3 | Mar 5 | M | 7,318 | $3.79 | $27,735 | 152,673 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 3 | Mar 5 | M | 6,237 | $3.79 | $23,638 | 158,910 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 3 | Mar 5 | S | 13,555 | $18.22 | Sale −$246,972 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 3 | Mar 5 | M · derivative | 7,318 | $3.79 | $27,735 | 58,144 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Mar 3 | Mar 5 | M · derivative | 6,237 | $3.79 | $23,638 | 82,747 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Mar 3 | Mar 5 | M | 12,892 | $3.79 | $48,861 | 222,533 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Mar 3 | Mar 5 | S | 12,892 | $18.16 | Sale −$234,119 | 209,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Mar 3 | Mar 5 | S | 4,500 | $18.16 | Sale −$81,720 | 205,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Mar 3 | Mar 5 | M · derivative | 12,892 | $3.79 | $48,861 | 125,334 | Yes | Form 4 |
| Ra Capital Management, L.P. | Feb 26 | Mar 2 | P | 300,000 | $16.00 | Purchase +$4,800,000 | 4,603,418 | No | Form 4 |
| Ra Capital Management, L.P. | Feb 26 | Mar 2 | P · derivative | 2,200,000 | $16.00 | Purchase +$35,200,000 | 2,200,000 | No | Form 4 |
| Cohlhepp RyanPresident and COO | Feb 25 | Feb 27 | M | 3,108 | $3.79 | $11,779 | 213,272 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Feb 25 | Feb 27 | S | 3,108 | $18.04 | Sale −$56,068 | 210,164 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Feb 25 | Feb 27 | S | 523 | $18.04 | Sale −$9,435 | 209,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Feb 25 | Feb 27 | M · derivative | 3,108 | $3.79 | $11,779 | 138,226 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Feb 2 | Feb 4 | A · derivative | 90,000 | $16.76 | $1,508,400 | 90,000 | No | Form 4 |
| Hyep IvanChief Financial Officer | Feb 2 | Feb 4 | A · derivative | 125,000 | $16.76 | $2,095,000 | 125,000 | No | Form 4 |
| Raben DavidChief Medical Officer | Feb 2 | Feb 4 | A · derivative | 100,000 | $16.76 | $1,676,000 | 100,000 | No | Form 4 |
| Mazumdar ClaireChief Executive Officer | Feb 2 | Feb 4 | A · derivative | 450,000 | $16.76 | $7,542,000 | 450,000 | No | Form 4 |
| Cohlhepp RyanPresident and COO | Feb 2 | Feb 4 | A · derivative | 300,000 | $16.76 | $5,028,000 | 300,000 | No | Form 4 |
| Hyep IvanChief Financial Officer | Jan 22 | Jan 26 | M | 1,882 | $3.79 | $7,133 | 147,237 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Jan 22 | Jan 26 | S | 1,882 | $18.15 | Sale −$34,158 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Jan 22 | Jan 26 | M · derivative | 1,882 | $3.79 | $7,133 | 65,462 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Jan 22 | Jan 26 | S | 3,828 | $18.10 | Sale −$69,287 | 210,164 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Jan 15 | Jan 20 | S | 149 | $18.02 | Sale −$2,685 | 213,992 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Dec 26, 2025 | Dec 29, 2025 | M | 19,789 | $3.79 | $75,000 | 55,286 | No | Form 4 |
| Raben DavidChief Medical Officer | Dec 26, 2025 | Dec 29, 2025 | M · derivative | 19,789 | $3.79 | $75,000 | 98,987 | No | Form 4 |
| Cohlhepp RyanPresident and COO | Dec 26, 2025 | Dec 29, 2025 | M | 25,000 | $4.44 | $111,000 | 214,141 | No | Form 4 |
| Cohlhepp RyanPresident and COO | Dec 26, 2025 | Dec 29, 2025 | M · derivative | 25,000 | $4.44 | $111,000 | 39,909 | No | Form 4 |
| Hyep IvanChief Financial Officer | Dec 22, 2025 | Dec 23, 2025 | M | 9,200 | $3.79 | $34,868 | 154,555 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Dec 22, 2025 | Dec 23, 2025 | S | 9,200 | $18.31 | Sale −$168,452 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Dec 22, 2025 | Dec 23, 2025 | M · derivative | 9,200 | $3.79 | $34,868 | 88,984 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Dec 16, 2025 | Dec 18, 2025 | M | 29,500 | $5.45 | $160,775 | 339,392 | No | Form 4 |
| Mazumdar ClaireChief Executive Officer | Dec 16, 2025 | Dec 18, 2025 | M · derivative | 29,500 | $5.45 | $160,775 | 565,512 | No | Form 4 |
| Cohlhepp RyanPresident and COO | Dec 15, 2025 | Dec 16, 2025 | M | 8,000 | $3.79 | $30,320 | 201,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Dec 15, 2025 | Dec 16, 2025 | S | 8,000 | $18.68 | Sale −$149,440 | 193,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Dec 15, 2025 | Dec 16, 2025 | S | 4,500 | $18.68 | Sale −$84,060 | 189,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Dec 15, 2025 | Dec 16, 2025 | M · derivative | 8,000 | $3.79 | $30,320 | 141,334 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Nov 25, 2025 | Nov 25, 2025 | M | 4,594 | $3.79 | $17,411 | 40,091 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Nov 25, 2025 | Nov 25, 2025 | S | 4,594 | $18.84 | Sale −$86,551 | 35,497 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Nov 25, 2025 | Nov 25, 2025 | M | 906 | $3.79 | $3,434 | 36,403 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Nov 25, 2025 | Nov 25, 2025 | S | 906 | $18.84 | Sale −$17,069 | 35,497 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Nov 25, 2025 | Nov 25, 2025 | M · derivative | 4,594 | $3.79 | $17,411 | 118,776 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Nov 25, 2025 | Nov 25, 2025 | M · derivative | 906 | $3.79 | $3,434 | 69,413 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Nov 24, 2025 | Nov 25, 2025 | M | 17,795 | $3.79 | $67,443 | 163,150 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Nov 24, 2025 | Nov 25, 2025 | S | 17,795 | $18.55 | Sale −$330,097 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Nov 24, 2025 | Nov 25, 2025 | M · derivative | 17,795 | $3.79 | $67,443 | 98,184 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Nov 24, 2025 | Nov 25, 2025 | M | 41,163 | $3.79 | $156,008 | 351,055 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Nov 24, 2025 | Nov 25, 2025 | S | 41,163 | $18.86 | Sale −$776,334 | 309,892 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Nov 24, 2025 | Nov 25, 2025 | M · derivative | 41,163 | $3.79 | $156,008 | 236,107 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Nov 24, 2025 | Nov 25, 2025 | M | 5,500 | $3.79 | $20,845 | 40,997 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Nov 24, 2025 | Nov 25, 2025 | S | 5,500 | $18.45 | Sale −$101,475 | 35,497 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Nov 24, 2025 | Nov 25, 2025 | M · derivative | 5,500 | $3.79 | $20,845 | 123,370 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Nov 21, 2025 | Nov 25, 2025 | M | 8,000 | $3.79 | $30,320 | 206,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Nov 21, 2025 | Nov 25, 2025 | S | 8,000 | $18.05 | Sale −$144,400 | 198,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Nov 21, 2025 | Nov 25, 2025 | S | 4,500 | $18.05 | Sale −$81,225 | 193,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Nov 21, 2025 | Nov 25, 2025 | M · derivative | 8,000 | $3.79 | $30,320 | 149,334 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Nov 21, 2025 | Nov 25, 2025 | M | 605 | $3.79 | $2,293 | 145,960 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Nov 21, 2025 | Nov 25, 2025 | S | 605 | $18.15 | Sale −$10,981 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Nov 21, 2025 | Nov 25, 2025 | M · derivative | 605 | $3.79 | $2,293 | 115,979 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Oct 16, 2025 | Oct 20, 2025 | M | 24,103 | $3.79 | $91,350 | 333,995 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Oct 16, 2025 | Oct 20, 2025 | S | 24,103 | $18.83 | Sale −$453,859 | 309,892 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Oct 16, 2025 | Oct 20, 2025 | M · derivative | 24,103 | $3.79 | $91,350 | 277,270 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 15, 2025 | Oct 16, 2025 | M | 8,000 | $3.79 | $30,320 | 210,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 15, 2025 | Oct 16, 2025 | S | 8,000 | $18.16 | Sale −$145,280 | 202,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 15, 2025 | Oct 16, 2025 | S | 4,500 | $18.16 | Sale −$81,720 | 198,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 15, 2025 | Oct 16, 2025 | M · derivative | 8,000 | $3.79 | $30,320 | 157,334 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Oct 15, 2025 | Oct 15, 2025 | M | 13,289 | $3.79 | $50,365 | 323,181 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Oct 15, 2025 | Oct 15, 2025 | S | 13,289 | $18.84 | Sale −$250,365 | 309,892 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Oct 15, 2025 | Oct 15, 2025 | M · derivative | 13,289 | $3.79 | $50,365 | 301,373 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Oct 13, 2025 | Oct 15, 2025 | M | 11,445 | $3.79 | $43,377 | 321,337 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Oct 13, 2025 | Oct 15, 2025 | S | 11,445 | $18.92 | Sale −$216,539 | 309,892 | Yes | Form 4 |
| Mazumdar ClaireChief Executive Officer | Oct 13, 2025 | Oct 15, 2025 | M · derivative | 11,445 | $3.79 | $43,377 | 314,662 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 9, 2025 | Oct 10, 2025 | M | 6,415 | $3.79 | $24,313 | 151,770 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 9, 2025 | Oct 10, 2025 | S | 6,415 | $18.23 | Sale −$116,945 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 9, 2025 | Oct 10, 2025 | M · derivative | 6,415 | $3.79 | $24,313 | 116,584 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Oct 9, 2025 | Oct 10, 2025 | M | 22,000 | $3.79 | $83,380 | 57,497 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Oct 9, 2025 | Oct 10, 2025 | S | 22,000 | $18.45 | Sale −$405,900 | 35,497 | Yes | Form 4 |
| Raben DavidChief Medical Officer | Oct 9, 2025 | Oct 10, 2025 | M · derivative | 22,000 | $3.79 | $83,380 | 128,870 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 8, 2025 | Oct 8, 2025 | M | 5,627 | $3.79 | $21,326 | 150,982 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 8, 2025 | Oct 8, 2025 | S | 5,627 | $18.21 | Sale −$102,468 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 8, 2025 | Oct 8, 2025 | M · derivative | 5,627 | $3.79 | $21,326 | 122,999 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 7, 2025 | Oct 8, 2025 | M | 8,000 | $3.79 | $30,320 | 213,541 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 7, 2025 | Oct 8, 2025 | S | 8,000 | $18.06 | Sale −$144,480 | 205,541 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 7, 2025 | Oct 8, 2025 | S | 2,900 | $18.06 | Sale −$52,374 | 202,641 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 7, 2025 | Oct 8, 2025 | M · derivative | 8,000 | $3.79 | $30,320 | 165,334 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 7, 2025 | Oct 8, 2025 | M | 18,244 | $3.79 | $69,145 | 163,599 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 7, 2025 | Oct 8, 2025 | S | 18,244 | $18.22 | Sale −$332,406 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 7, 2025 | Oct 8, 2025 | M · derivative | 18,244 | $3.79 | $69,145 | 128,626 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 6, 2025 | Oct 8, 2025 | M | 24,000 | $3.79 | $90,960 | 245,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 6, 2025 | Oct 8, 2025 | S | 24,000 | $18.06 | Sale −$433,440 | 221,141 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 6, 2025 | Oct 8, 2025 | S | 15,600 | $18.06 | Sale −$281,736 | 205,541 | Yes | Form 4 |
| Cohlhepp RyanPresident and COO | Oct 6, 2025 | Oct 8, 2025 | M · derivative | 24,000 | $3.79 | $90,960 | 173,334 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 6, 2025 | Oct 8, 2025 | M | 6,514 | $3.79 | $24,688 | 151,869 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 6, 2025 | Oct 8, 2025 | S | 6,514 | $18.17 | Sale −$118,359 | 145,355 | Yes | Form 4 |
| Hyep IvanChief Financial Officer | Oct 6, 2025 | Oct 8, 2025 | M · derivative | 6,514 | $3.79 | $24,688 | 146,870 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Sep 29, 2025 | Oct 1, 2025 | M | 33,807 | $9.24 | $312,377 | 33,807 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Sep 29, 2025 | Oct 1, 2025 | S | 33,807 | $14.75 | Sale −$498,653 | not reported | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Sep 29, 2025 | Oct 1, 2025 | M · derivative | 33,807 | $9.24 | $312,377 | 101,423 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Sep 15, 2025 | Sep 17, 2025 | M | 15,829 | $5.45 | $86,268 | 15,829 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Sep 15, 2025 | Sep 17, 2025 | S | 15,829 | $11.49 | Sale −$181,875 | not reported | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Sep 15, 2025 | Sep 17, 2025 | M · derivative | 6,085 | $5.45 | $33,163 | 54,769 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Sep 15, 2025 | Sep 17, 2025 | M · derivative | 9,744 | $5.45 | $53,105 | 87,699 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Jun 16, 2025 | Jun 18, 2025 | M | 15,829 | $5.45 | $86,268 | 15,829 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Jun 16, 2025 | Jun 18, 2025 | S | 15,829 | $10.43 | Sale −$165,096 | not reported | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Jun 16, 2025 | Jun 18, 2025 | M · derivative | 6,085 | $5.45 | $33,163 | 60,854 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Jun 16, 2025 | Jun 18, 2025 | M · derivative | 9,744 | $5.45 | $53,105 | 97,443 | Yes | Form 4 |
| RA Capital Nexus Fund III, L.P. | Jun 9, 2025 | Jun 10, 2025 | A · derivative | 23,746 | $11.48 | $272,604 | 23,746 | No | Form 4 |
| Bowden Christopher | Jun 9, 2025 | Jun 10, 2025 | A · derivative | 23,746 | $11.48 | $272,604 | 23,746 | No | Form 4 |
| Simson Jake | Jun 9, 2025 | Jun 10, 2025 | A · derivative | 23,746 | $11.48 | $272,604 | 23,746 | No | Form 4 |
| Robertson Scott M. | Jun 9, 2025 | Jun 10, 2025 | A · derivative | 23,746 | $11.48 | $272,604 | 23,746 | No | Form 4 |
| Lonberg Nils | Jun 9, 2025 | Jun 10, 2025 | A · derivative | 23,746 | $11.48 | $272,604 | 23,746 | No | Form 4 |
| Powell Michael | Jun 9, 2025 | Jun 10, 2025 | A · derivative | 23,746 | $11.48 | $272,604 | 23,746 | No | Form 4 |
| Mazumdar-Shaw Kiran | Jun 9, 2025 | Jun 10, 2025 | A · derivative | 23,746 | $11.48 | $272,604 | 23,746 | No | Form 4 |
| Haviland Kate | Jun 9, 2025 | Jun 10, 2025 | A · derivative | 23,746 | $11.48 | $272,604 | 23,746 | No | Form 4 |
| Meisner LaraChief Legal Officer | Mar 14, 2025 | Mar 18, 2025 | M | 79,146 | $5.45 | $431,346 | 79,145 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Mar 14, 2025 | Mar 18, 2025 | S | 48,526 | $12.69 | Sale −$615,795 | 30,620 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Mar 14, 2025 | Mar 18, 2025 | S | 30,620 | $13.24 | Sale −$405,409 | not reported | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Mar 14, 2025 | Mar 18, 2025 | M · derivative | 48,720 | $5.45 | $265,524 | 107,187 | Yes | Form 4 |
| Meisner LaraChief Legal Officer | Mar 14, 2025 | Mar 18, 2025 | M · derivative | 30,246 | $5.45 | $164,841 | 67,119 | Yes | Form 4 |
| Fmr LLC | Sep 16, 2024 | Sep 18, 2024 | C | 10,818 | not reported | not reported | 10,818 | No | Form 4 |
| Fmr LLC | Sep 16, 2024 | Sep 18, 2024 | C | 712,430 | not reported | not reported | 723,248 | No | Form 4 |
| Fmr LLC | Sep 16, 2024 | Sep 18, 2024 | C | 392,085 | not reported | not reported | 1,115,333 | No | Form 4 |
| Fmr LLC | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 10,818 | not reported | not reported | not reported | No | Form 4 |
| Fmr LLC | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 712,430 | not reported | not reported | not reported | No | Form 4 |
| Fmr LLC | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 392,085 | not reported | not reported | not reported | No | Form 4 |
| FIL Ltd | Sep 16, 2024 | Sep 18, 2024 | C | 54,092 | not reported | not reported | 54,092 | No | Form 4 |
| FIL Ltd | Sep 16, 2024 | Sep 18, 2024 | C | 606,885 | not reported | not reported | 660,977 | No | Form 4 |
| FIL Ltd | Sep 16, 2024 | Sep 18, 2024 | C | 352,876 | not reported | not reported | 1,013,853 | No | Form 4 |
| FIL Ltd | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 54,092 | not reported | not reported | not reported | No | Form 4 |
| FIL Ltd | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 606,885 | not reported | not reported | not reported | No | Form 4 |
| FIL Ltd | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 352,876 | not reported | not reported | not reported | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Sep 16, 2024 | Sep 18, 2024 | C | 2,622,898 | not reported | not reported | 2,622,898 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Sep 16, 2024 | Sep 18, 2024 | C | 2,500,095 | not reported | not reported | 2,500,095 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Sep 16, 2024 | Sep 18, 2024 | P | 1,680,520 | $18.00 | Purchase +$30,249,360 | 4,303,418 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Sep 16, 2024 | Sep 18, 2024 | P | 152,480 | $18.00 | Purchase +$2,744,640 | 2,652,575 | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 18,409,755 | not reported | not reported | not reported | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 12,273,169 | not reported | not reported | not reported | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 5,835,024 | not reported | not reported | not reported | No | Form 4 |
| RA Capital Nexus Fund III, L.P. | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 10,836,474 | not reported | not reported | not reported | No | Form 4 |
| Bonderman David | Sep 16, 2024 | Sep 18, 2024 | C | 1,960,425 | not reported | not reported | 1,960,425 | No | Form 4 |
| Bonderman David | Sep 16, 2024 | Sep 18, 2024 | C · derivative | 18,121,194 | not reported | not reported | not reported | No | Form 4 |
| Deerfield Private Design Fund V, L.P. | Sep 17, 2024 | Sep 17, 2024 | C | 862,587 | not reported | not reported | 862,587 | No | Form 4 |
| Deerfield Private Design Fund V, L.P. | Sep 17, 2024 | Sep 17, 2024 | C | 862,587 | not reported | not reported | 862,587 | No | Form 4 |
| Deerfield Private Design Fund V, L.P. | Sep 17, 2024 | Sep 17, 2024 | P | 35,000 | $18.00 | Purchase +$630,000 | 897,587 | No | Form 4 |
| Deerfield Private Design Fund V, L.P. | Sep 17, 2024 | Sep 17, 2024 | P | 35,000 | $18.00 | Purchase +$630,000 | 897,587 | No | Form 4 |
| Deerfield Private Design Fund V, L.P. | Sep 17, 2024 | Sep 17, 2024 | C · derivative | 7,973,325 | not reported | not reported | not reported | No | Form 4 |
| Deerfield Private Design Fund V, L.P. | Sep 17, 2024 | Sep 17, 2024 | C · derivative | 7,973,325 | not reported | not reported | not reported | No | Form 4 |
| Mazumdar-Shaw Kiran | Sep 16, 2024 | Sep 16, 2024 | C | 4,327,365 | $0.00 | $0 | 4,443,122 | No | Form 4 |
| Mazumdar-Shaw Kiran | Sep 16, 2024 | Sep 16, 2024 | C | 1,080,775 | $0.00 | $0 | 1,080,775 | No | Form 4 |
| Mazumdar-Shaw Kiran | Sep 16, 2024 | Sep 16, 2024 | C | 324,552 | $0.00 | $0 | 324,552 | No | Form 4 |
| Mazumdar-Shaw Kiran | Sep 16, 2024 | Sep 16, 2024 | C | 432,736 | $0.00 | $0 | 432,736 | No | Form 4 |
| Mazumdar-Shaw Kiran | Sep 16, 2024 | Sep 16, 2024 | C · derivative | 40,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Mazumdar-Shaw Kiran | Sep 16, 2024 | Sep 16, 2024 | C · derivative | 9,990,144 | $0.00 | $0 | not reported | No | Form 4 |
| Mazumdar-Shaw Kiran | Sep 16, 2024 | Sep 16, 2024 | C · derivative | 3,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Mazumdar-Shaw Kiran | Sep 16, 2024 | Sep 16, 2024 | C · derivative | 4,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Biocon Ltd | Sep 16, 2024 | Sep 16, 2024 | C | 4,327,365 | $0.00 | $0 | 4,443,122 | No | Form 4 |
| Biocon Ltd | Sep 16, 2024 | Sep 16, 2024 | C | 1,080,775 | $0.00 | $0 | 1,080,775 | No | Form 4 |
| Biocon Ltd | Sep 16, 2024 | Sep 16, 2024 | C · derivative | 40,000,000 | $0.00 | $0 | not reported | No | Form 4 |
| Biocon Ltd | Sep 16, 2024 | Sep 16, 2024 | C · derivative | 9,990,144 | $0.00 | $0 | not reported | No | Form 4 |
| Mazumdar-Shaw Kiran | Sep 12, 2024 | Sep 16, 2024 | A · derivative | 23,746 | $18.00 | $427,428 | 23,746 | No | Form 4 |
| Robertson Scott M. | Sep 12, 2024 | Sep 16, 2024 | A · derivative | 23,746 | $18.00 | $427,428 | 23,746 | No | Form 4 |
| Haviland Kate | Sep 12, 2024 | Sep 16, 2024 | A · derivative | 23,746 | $18.00 | $427,428 | 23,746 | No | Form 4 |
| Simson Jake | Sep 12, 2024 | Sep 16, 2024 | A · derivative | 23,746 | $18.00 | $427,428 | 23,746 | No | Form 4 |
| Lonberg Nils | Sep 12, 2024 | Sep 16, 2024 | A · derivative | 23,746 | $18.00 | $427,428 | 23,746 | No | Form 4 |
| Ra Capital Management, L.P. | Sep 12, 2024 | Sep 16, 2024 | A · derivative | 23,746 | $18.00 | $427,428 | 23,746 | No | Form 4 |